Article Information
History
- May 24, 2024.
Article Versions
- Version 1 (October 23, 2023 - 12:31).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Peter T. Bell1,2,3,#,
- Timothy Baird1,2,4,#,
- John Goddard1,7,
- Olusola S. Olagoke2,4,
- Andrew Burke3,5,
- Shradha Subedi2,6,
- Tiana R. Davey2,4,
- James Anderson1,7,
- Derek S. Sarovich2,4,# and
- Erin P. Price2,4,*,#
- 1Department of Respiratory Medicine, Sunshine Coast University Hospital, Birtinya, Queensland, Australia
- 2Sunshine Coast Health Institute, Birtinya, Queensland, Australia
- 3School of Medicine, University of Queensland, Herston, Queensland, Australia
- 4Centre for Bioinnovation, University of the Sunshine Coast, Sippy Downs, Queensland, Australia
- 5Department of Respiratory and Thoracic Medicine, The Prince Charles Hospital, Chermside, Queensland, Australia
- 6Department of Infectious Diseases, Sunshine Coast University Hospital, Birtinya, Queensland, Australia
- 7School of Medicine and Dentistry, Griffith University, Sunshine Coast, Queensland, Australia
- ↵*Corresponding Author Erin P. Price University of Sunshine Coast eprice{at}usc.edu.au +61 7 5456 5568
↵# Authors contributed equally
Posted May 24, 2024.
Evaluating the feasibility, sensitivity, and specificity of next-generation molecular methods for pleural infection diagnosis
